CURRICULUM VITAE EDUCATION:

Transcription

1 CURRICULUM VITAE CONTACT: Name: Asst. Prof. Lazar Popović, MD, PhD Licence number: Date of birth: in Novi Sad, Serbia Address: Home: Vojvode Šupljikca 9/31, Novi Sad Job: Clinic of medical oncology, Oncology Institute of Vojvodina, Put dr Goldmana 4, Sremska Kamenica, Serbia Phone numbers: Mobile: Job: , EDUCATION: Gymnasium Jovan Jovanović Zmaj, in Novi Sad, science and mathematics, Medicical faculty, in Novi Sad, Medicine doctor average 9,39/ Specialisation: Internal medicine Subspecialisation: Oncology 2014 PhD Significance of molecular markers expression in prognosis of diffuse large B-cell lymphoma treated with immunochemotherapy WORKING EXPIRIENCE: One year intership: Clinic for nephrology and clinical immunology, Clinical Centre of Vojvodina Medical doctor: Clinic for medical oncology, Oncology Institute of Vojvodina Medical doctor, Internal medicine consultant: Clinic for medical oncology, Oncology Institute of Vojvodina Medical doctor, Internal medicine consultant, oncology subspecialist: Clinic for medical oncology, Oncology Institute of Vojvodina Teaching assistent: Department of oncology, Medical faculty, Univeristy of Novi Sad Assistant Professor: Department of oncology, Medical faculty, Univeristy of Novi Sad FOREIGN LANGUAGES: English-fluently German-beginner course (DAAD)

2 EDUCATION and EXPIRIENCE: 2008 Professional education: Tenon Hospital, Paris, Medical Oncology and stem cell transplantation unit (Prof Lotz/ Prof Gligorov) 2016 ESMO Clinical Unit Visit Fellowship Grant: Oncology Institute Southern Switzerland, Lymphoma Unit, Breast Cancer Unit, Phase 1 Trials Unit (Prof Cavalli/Prof Ghielmini/Dr Zucca/Dr Pagani/Dr Stathis) 2006 Course Apheresis on Cobe spectra 2007 GCP course certificate 2012 GCP recerification Quintiles 2008 EBMT-Lymphoma working party training course 2009 EBMT-Infectious diseases working party training course 2011 EBMT-Medical statistics course 2012 Top 10 Teaching assistants at Medical Faculty of Novi Sad-Award of Students MEMBERSHIPS: BUON (Balkans Union of Oncology) member ESMO (European Society for Medical Oncology) member ESMO YO-National Representative SLG (Serbian Lymphoma Study Group) member SLD (Serbian Medical Society) member AROME JUNIOR executive board member-research co-ordinator AJOC (AROME Junior Oncologist Committee)-hematological malignancies co-coordinator AROME (Association of Radiotherapy and Oncology in the Mediterranean Area) national board member NOVI SAD ONCOLOGY CONGRESS 2009., and Head of Congress Secretariat NOVI SAD ONCOLOGY CONGRESS 2014., Organizing committee member ARCHIVE OF ONCOLOGY journal editor ARCHIVE OF ONCOLOGY journal Editor-in-Chief ONCOLOGY INSTITUE OF VOJVODINA DRG IMPLEMENTATION TEAM ONCOLOGY INSTITUTE OF VOJVODINA ACREDITATON TEAM (Medical oncology dept and Information technologies teams) PROJECTS Maintaining Quality of Oncology Service in Autonomous Province of Vojvodina - Educational Project, Minsitry of Health, Autonomous Province of Vojvodina CLINICAL TRIALS: PRINCIPLE INVESTIGATOR: PHASE III: The Effect of Atezolizumab in Combination With Gemcitabine/Carboplatin and Gemcitabine/Carboplatin Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-based Therapy (Imvigor130) PHASE I: TO-TAS A Phase 1, Open-Label, Study to Evaluate the Safety, Tolerabillity, and Pharmacokinetics of TAS-102 in Patients with Advanced Solid Tumors and Varying Degrees of Renal Impairment PHASE III: A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogeneicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in

3 Patients with Low Tumor Burden Follicular Lymphoma PHASE III: A Phase III, Open-Label, Multicenter, Randomized Study To Investigate The Efficacy And Safety Of MPDL3280A (Anti PD-L1 Antibody, Atezolizumab) Compared With Chemotherapy In Patients With Locally Advanced Or Metastatic Urothelial Bladder Cancer After Failure With Platinum-Containing Chemotherapy PHASE III: A phase 3, multicenter, randomized, double-blind, active control study to evaluate the safety and efficacy of IV pro-netupitant/palonosetron (260 mg/0.25 mg) combination for the prevention of chemotherapy-induced nausea and vomiting in repeated chemotherapy cycles in patients receiving highly emetogenic chemotherapy PHASE IV: DIREGL07274-Metastatic Castrate Resistant Prostate Cancer-Serbian Registry SUB-INVESTIGATOR: PHASE I: Her-2 positive breast cancer; Aggressive Lymphoma. PHASE II: Multiple myeloma, Diffuse Large B-Cell Lymphoma, Low Grade Lymphoma PHASE III: Bladder Cancer-Immunotherapy (anti-pd-l1 adjuvant), Multiple myeloma, Breast cancer (4 trials); Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Cancer and Coagulation (2 trials), Glioblastoma, Melanoma. PHASE IV: Diffuse Large B-cell Lymphoma (2 trials), Follicular Lymphoma (2 trials), CLL, Mantle Cell Lymphoma INTERESTS and KNOWLEDGE: Breast cancer Urological cancers Lymphoma/CLL Multiple myeloma Biomarkers and signaling pathways in cancer Target therapy Autologous stem cell transplantation Supportive care in cancer Pharmacoeconomy and management Clinical trials MARITAL STATUS: Married: Spouse Milica Popovic, medical doctor, internal medicine consultant (nephrology and clinical immunology dept.) Two children: Tatjana born 2007, Stevan born FREE TIME: Sport: basketball, soccer, swimming Music: playing drums

4 REFERENCES: BOOKS: 1. Milic-Torres V, Popovic L, Vaz F, Penque D Proteomics in the Assessment of the Therapeutic Response of Antineoplastic Drugs: Strategies and Practical Applications in Ruef J and Sebastiao Rodrigues Casncer Drug Resistance: Overview and Methods. Methods in Molecular Biology vol 1395 DOI / _16 Springer Science+Business Media New York Cvetanovic A, Filipovic S, Vrbic S, Pejcic I, Popovic L Side effects of cetuximab: rash in Madison R Hall. Head and neck cancer: epidemiology, management and treatment outcomes Nova Science Publishers 2015 ISBN: Popovic L., Grgic Z., Popovic M. Melanoma during pregnancy in Armstrong A. Advances in Malignant Melanoma: Clinical and Research Perspectives InTech 2011 ISBN Lucic S, Lučić M, Peter A, Erak M, Popovic-Petrovic S, Kukić B, Popović L, Đuran B. PET/CT in diagnosis of cancer of unkown primary, Aktuelnosti u u medicini i, stomatologiji i farmaciji: Zbornik radova :Medicinski fakultet Novi Sad 2010 (serbian) PAPERS: 1. Popovic L, Popovic M Editorial Comment to Clinical Analysis Of Severe Psychiatric Disorders In Patients With Testicular Cancer: A Single-Center Experience Int J Urol (ahead of print) Popovic Dj, Popovic L Obesity and breast cancer - association even more relevant in males? Eur J Intern

5 Med 2016 Apr;29:e Popovic L, Matovina-Brko G, Popovic M, Petrovic D, Cvetanovic A, Vukojevic J, Jovanovic D High dose chemotherapy with stem cell support in the treatment of testicular cancer World J Stem Cells 2015; 7(11): Cvetanovic A, Popovic L, Filipovic S, Trifunovic J, Zivkovic N, Matovina-Brko G, Kostic M; Vicko F, Kocic B, Kolarov-Bjelobrk I Young Age and Pathological Features Predict Breast Cancer Outcome-report from a Dual Institution Expirience in Serbia J BUON 2015; 20(6): Jovanovic D,Petrovic D, Popovic L Target therapy for patients with Non-Hodgkin Lymphomas 3rd Congress of Hematologist Serbia 2015 PP24: O. Markovic, L. Popović, D. Marisavljevic, J. Hajder R., Živković, N. Stanisavljevic, D. Jovanovic, B. Filipovic, D. Stanisavljevic, G. Matovina-Brko, T. Matkovic,, M. Todorović, D. Petrovic, B. Mihaljevic Prognostic Impact Analysis of absolute lymphocyte count (ALC) and absolute monocyte count (AMC) in patients with Diffuse Large B-Cell Lymphoma 3rd Congress of Hematologist Serbia 2015 OP23: S.Popovic, B.Mihaljevic, N.Vlaisavljevic, L.Popovic, S.Salma, D.Agic, R.Milosevic,M.Smiljanic, S.Sretenovic, P.Djurdjevic,O.Markovic, J.Hajder, N.Govedarevic, D.Zivic, I. Savic, D.Jovanovic, N.Andjelkovic, T. Vukicevic, D.Marisavljevic Rituximab in the treatment of stge III and IV Follicular Lymphoma: Serbian Lymphoma Study Group Reflekt 1 results 3rd Congress of Hematologist Serbia 2015 OP25: Popovic L, Matovina-Brko G. Anti-PD1/PD-L1 checkpoint inhibitors: a new frontier in cancer immunotherapy The second congress of the Serbian association for cancer research Proceedings book 2015 OP04: Popovic L. Breast Cancer in very young woman X UMOS Conference Proceedings Book Popovic L. Target therapy in the treatment of Hodgkin Lymphoma VI NSOC Proceedings Book Popovic L, Jovanovic D, Knezevic-Usaj S, Nikin Z, Popovic Dj, Matovina-Brko G, Popovic M, Petrovic D The Expression of Molecular Markers As a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treatment in Rituximab Era 1st ESHInternational Conference on New Concepts in B Cell Malignancies: From Molecular Pathogenesis to Personilized Treatment Abstr Popovic L., Jovanovic D., Petrovic D., Nikin Z., Matovina-Brko G., Trifunovic J., Kolarov-Bjelobrk I. Concurrent Chronic Lymphocytic Leukemia And Merkel Cell Carcinoma In Primary Skin Tumor And Metastatic Lymph Node Indian J Hematol Blood Transfus 2014 Sep;30(Suppl 1): Popovic L, Trifunovic J, Pesic J, Matovina-Brko G, Kolarov-Bjelobrk I, Memisevic N, Jovanovic D Male Breast Cancer In The Era Of Modern Therapies: Serbian Single Centre Experience Report Breast J 2014 Apr 8. May;20(3): O. Markovic, L. Popović, D. Marisavljevic, D. Jovanovic, B. Filipovic, D. Stanisavljevic, G. Matovina-Brko, J. Hajder, T. Matkovic, R. Živković, N. Stanisavljevic, M. Todorović, D. Petrovic, B. Mihaljevic Comparison of prognostic impact of absolute lymphocyte count (ALC), absolute monocyte count (AMC), ALC/AMC prognostic score and ALC/AMC ratio in patients with diffuse large B cell lymphoma Eur J Intern Med 2014 Mar;25(3): L. Popovic, O. Markovic, D. Jovanovic, D. Marisavljevic, D. Petrovic, B. Mihaljevic, Z. Nikin, T. Matkovic, G. Matovina-Brko, R. Zivkovic Differences in baseline characteristics and survival rates between GCB and non-gcb diffuse large B-cell lymphoma treated with rituximab based immunochemotherapy EJC Suppl 2013 ECCO-ESMO abstract 3629

6 16. L. Popovic, O. Markovic, D. Jovanovic, D. Marisavljevic, D. Petrovic, B. Mihaljevic, M. Popovic, T. Matkovic, G. Matovina-Brko, R. Zivkovic CD5-positive versus CD5-negative diffuse large B-cell lymphoma treated with immunochemotherapy: Is there a difference? EJC Suppl 2013 ECCO-ESMO abstract L. Popovic, Z. Nikin, D. Jovanovic, S. Knezevic-Usaj, M. Popovic, G. Matovina-Brko BAFF, TACI and BCMA receptors expression and their impact on survival of patients with diffuse large b-cell lymphoma EJC Suppl 2013 ECCO-ESMO abstract Matovina-Brko G., Ruzic M., Fabri M., Popovic L., Kolarov-Bjelobrk I., Trifunovic J., Petkovic D. Treatment of acute hepatitis C in breat cancer patient J chemother 2014 Jun;26(3): Matovina-Brko G, Nikolin B, Popovic L, Nikin Z, Jovanovic D, Popovic-Petrovic S. Paratesticular rhabdomyosarcoma of a young adult: a case report with review of the literature. Contemporary Oncology 2013 (ahead of print) 20. Markovic O, Popovic L, Marisavljevic D, Jovanovic D, Mihaljevic B, Stanisavljevic D, Hajder J, Zivkovic R, Petrovic D, Stanisavljevic N, Matovina-Brko G, Todorovic M, Bila J Prognostic Significance Of Low Lymphocytes Count In The Patients With Diffuse Large B Cell Lymphoma (DLBCL) Haematologica 2013 (EHA Abstract) 21. B. Mihaljevic, D. Jovanovic, N. Andjelkovic, S. Popovic, T. Vukicevic, B. Andjelic,6 L. Popovic, M. Todorovic, N. Vlaisavljevic, A. Sretenovic, P. Djurdjevic, S. Sretenovic, S. Jankovic, O. Markovic, G. Marjanovic, S. Vrbic, J. Hajder, D. Zivic. Maximizing therapeutic benefit of rituximab for Relapsed/resistant follicular lymphoma: 2 years maintenance therapy results Hematol Oncol 2013: 31 (suppl. 1): Lučić S, Peter A, Jovanović D, Popović L, Lučić A M, Kozarski D, Spirovski M Role Of 18f-Fdg Pet/Ct In Patients With Follicular Lymphoma 2 nd Balkan Congress of Nuclear Medicine, Popovic L, Popovic M, Jelic M Resistance to rituximab treatment: mechanisms and therapeutic inteventions. Med Danas 2013 (Ahead of print) (serbian) 24. Popovic L., Jovanovic D., Popovic Dj. CD30-the head of the TNF familiy...or the successful story of brentuximab-vedotin Arch Oncol 2013; 21 (1): Jelic M, Jovanovic D, Popovic L, Striber-Devaja D Monoclonal antibodies at the Oncology Institute of Vojvodina-5 year expenditure Arch Oncol 2012; 20(3-4): Popovic Dj, Popovic L, Stokic E, Tomic-Naglic D, Mitrovic M, Kovačev-Zavisic B Influence of metformin therapy on breast cancer incidence and prognosis. Arch Oncol 2012; 20(3-4): L. Popovic, D. Jovanovic, D. Donat, D. Petrovic, T. Roganovic, J.-P. Lotz High dose chemotherapy with autologous stem cell transplantation for the patients with germ-cell cancer J BUON 2013; 18(1): Lucic S, Peter A, Jovanovic D, Popovic L, Petrovic D, Lucic M 18F-FDG PET/CT diagnostic value in the temporal follow-up of lymphoma patients. Eur J Nucl Med Mol Imaging 2012; 39: S Petrovic D., Jovanovic D., Popovic L. Risk models for predicting chemotherapy-induced neutropenia in patients with solid tumors and malignant lymphoma Haematologica 2012 (EHA

7 2012; abstr 1784) 30. B Mihaljevic,D Antic,B Andjelic,L Popovic,D Agic,V Nikolic,S Sretenovic,V Vukovic New prognostic model in follicular non-hodgkin lymphoma treated with rituximab chop: association of comorbidities with overall survival Haematologica 2012 (EHA 2012 abstr 1698) 31. B Andjelic,D Antic,V Nikolic,L Popovic,V Vukovic,B Mihaljevic The impact of comorbidity burden on the overall survival in patients with diffuse large B-cell lymphoma Haematologica 2012 (EHA 2012 abstr 1701) 32. Petrovic-Popovic S, Tomic S, Nedeljkovic M, Popovic L, Matovina G Early rehabilitation in patients with breast carcinoma Vojnosanit Pregl Apr;70(4): Popovic-Petrovic S, Nedeljkovic M, Popovic L, Petrovic V Secondary Lymphedema of the arm in breast carcinoma at the Oncology institute of Vojvodina: Healthmed 2011; 5(6): Popovic L., Jovanovic D., Petrovic D., Sundji A., Petrovic N., Roganovic T., Kukic B. Prognostic factors in the treatment of primary extranodal diffuse large B-cell lymphoma with rituximab-based immunochemotherapy Haematologica 2011; 96 (Supp 2): B. Mihaljevic, D. Antic, B. Andjelic, M. Todorovic, T. Vukicevic, V. Nikolic, I. Pejcic, I. Petkovic, S. Popovic, L. Popovic, N. Andjelkovic, S. Sretenovic, M. Smiljenic, O. Markovic, J. Knezevic Prognostic significance of the Ki-67 index in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP-expirience of Serbian Lymhoma Study group Haematologica 2011; 96 (Supp 2): B. Mihaljevic, D. Antic, B. Andjelic, T. Vukicevic, V. Nikolic, I. Pejcic, I. Petkovic, S. Popovic, L. Popovic, N. Andjelkovic, S. Sretenovic, D. Lekovic, M. Smiljanic, O. Markovic, V. Knezevic, V. Kecman Characteristics of 917 Non-Hodgkin's lymphoma patients in Serbia according to the WHO classification of lymphoid neoplasms-lira national register-basd study Ann Oncol 2011; 22 (Supp 4): iv B. Mihaljevic, B. Andjelic, D. Antic, M. Todorovic, T. Vukicevic, V. Nikolic, I. Pejcic, I. Petkovic, S. Popovic, I Savic., L. Popovic, N. Andjelkovic, S. Sretenovic, J. Knezevic, V. Kecman Diffuse large B-cell lymphoma: germinal center vs non germinal center-treatment response on immunochemotherapy. Serbian Lymphoma Study group Ann Oncol 2011; 22 (Supp 4):iv Jovanovic D., Popovic L. et al Role of PET/CT in diagnosis and treatment of Lymphoma Haematology Congress of Bosnia and Herzegovina, Sarajevo, May Jovanovic Da, Petrovic D., Popovic L., Bjelobrk-Kolarov I., Jovanovic Du. Thromboprophylaxis in hospitalized cancer patients Hematol Rep 2011; 3(Supp 1): Stankov K., Bogdanovic G., Kojic V, Stankov S., Jojic N., Popovic L., Popovic S. Expression analysis of genes involved in epigenetic regulation and apoptosis in human malignant cell lines treated by 5-Azacitidine J BUON 2011;16 (1): L. Popovic, D. Jovanovic, D. Donat, D. Petrovic, T. Roganovic, J.-P. Lotz High-dose chemotherapy with autologous stem cell support for the heavily pretreated patients with germ cell tumours: a Serbian single-centre first-experience report Bone Marrow Transpl 2011; 46(Supp 1): L. Popovic, D. Jovanovic, D. Petrovic, A. Sundji, N. Petrovic, T. Roganovic, B. Kukic

8 Treatment of Primary Extranodal Diffuse Large B-cell Lymphoma with Immunochemotherapy- Our Expirience 2 nd Serbian Heamatology Congress/6 th Balkan Day of Haematology Abstract Book Nov 2011: L. Popovic, D. Jovanovic, D. Petrovic, N. Petrovic, A. Sundji, T. Roganovic, G. Matovina- Brko Significance of Standard Prognostic Scores (IPI and R-IPI) in Prognosis of Diffuse Large B-cell Lymphoma Patients treated with Immunochemotherapy 2 nd Serbian Heamatology Congress/6 th Balkan Day of Haematology Abstract Book Nov 2011: B. Mihaljevic, D. Jovanovic, N. Andjelkovic, S. Popovic, T. Vukicevic, B. Andjelic, L. Popovic, M. Todorovic, N. Vlaisavljevic, A. Sretenovic, P. Djurdjevic, S. Sretenovic, S. Jankovic, O. Markovic, G. Marjanovic, S. Vrbic, J. Hajder, D. Zivic Rituximab in combination with Chemotherapy in Patients with Relapsed/Refractory Follicular NHL-Serbian Lymphoma Study Group Expirience. 2 nd Serbian Heamatology Congress/6 th Balkan Day of Haematology Abstract Book Nov 2011: D. Agic, I. Savic, S. Popovic, I. Percic, V. Kvrgic, B. Sekulic, B. Andjelic, D. Antic, L. Popovic, D. Jovanovic, T. Vukicevic, N. Andjelkovic, S. Vrbic, V. Nikolic, S. Sretenovic, B. Mihaljevic Spread of Diffuse Large B-cell Lymphoma in Serbian Patients 2 nd Serbian Heamatology Congress/6 th Balkan Day of Haematology Abstract Book Nov 2011: V. Nikolic, D. Antic, B. Andjelic, M. Todorovic, T. Vukicevic, I. Pejcic, I. Petkovic, S. Popovic, L. Popovic, N. Andjelkovic, S. Sretenovic, O. Markovic, J. Knezevic, B. MIhaljevic Prognostic significance of Ki-67 index in Patients with Diffuse Large B-cell Lymphoma treated with Rituximab plus CHOP-Serbian Lymphoma Study Group Expirience 2 nd Serbian Heamatology Congress/6 th Balkan Day of Haematology Abstract Book Nov 2011: S. Sretenovic, N. Andjelkovic, D. Antic, B. Andjelic, T. Vukicevic, V. Nikolic, S. Popovic, L. Popovic, O. Markovic, J. Knezevic, B. Mihaljevic Pospective non-selective Study of patients with Lymphoproliferative Neoplasms in Serbia-LIRA National Register 2 nd Serbian Heamatology Congress/6 th Balkan Day of Haematology Abstract Book Nov 2011: B. Andjelic, D. Antic, V. Nikolic, L. Popovic, V. Vukovic, B. Mihaljevic Prognostic Significance of Comorbidity Indeces in Diffuse Large B-Cell Lymphoma 2 nd Serbian Heamatology Congress/6 th Balkan Day of Haematology Abstract Book Nov 2011: B. Mihaljevic, D. Antic, B. Andjelic, D. Lekovic, D. Jovanovic, L. Popovic, T. Vukicevic, I. Pejcic, N. Andjelkovic, P. Djurdjevic, O. Markovic High ki-67 protein expression as prognostic factor in diffuse large B-cell lymphoma experience of Serbian Lymphoma study Group Abstract 416; International Society of Haematology Congress, Jerusalem, Israel Popovic L, Jovanovic D., Matovina-Brko G., Petrovic D., Nikin Z, Roganovic T. Primary diffuse large B-cell lymphoma of the breast Arch Oncol 2009; 17 (3-4): Grgic Z, Oros A, Rasic D, Popovic L, Popovic M Ocular malignant melanoma in pregnancy: is a happy ending possible? Arch Oncol 2009; 17 (3-4): Popovic L, Jovanovic D, Petrovic D, Matovina G, Roganovic T. ALK-negative large cells lymphoma in sceletal muscle-case report. Medicina Danas 2009; 8(7-9): (serbian) 53. Stankov K, Tauszig-Delamasure S, Bogdanovic G, Popovic L, Stankov S, Sylvisus N, Popovic S, Mehlen P. Expression of the genes involved in apoptosis, proliferation and endoplasmic reticulum stress in ionomycin/pma treated Jurkat cells EJC Supplements (2008), 6(12):

9 54. Stankov, K; Bogdanovic, G; Popovic L; Popovic, S; Tauszig-Delamasure, S; Mehlen, P; Sylvius,N Expression of c-kit/scf tyrosine kinase signaling pathway and apoptotic genes in ionomycin/pma treated Jurkat cells EJC Supplements (2008), 6(9): Andrijevic LJ, Aleksic L, Baltic M, Popovic L, Jovanovic D, Petrovic D, Matovina G. Enumeration of haematopoietic CD34+ stem cells by flowcytometry. Balkan flow users meeting Rovinj Croatia Popovic L. Rituximab maintenance therapy in follicular lymphoma Arch Oncol 2008;16(1-2): Popovic L. Anti-CD20 MAB(s)..., but not...thera. Arch Oncol 2008; 16(1-2): Popovic L., Jovanovic D., Petrovic D., Matovina G., Roganovic T. Rituximab in combination with chemotherapy in treatment of diffuse large B-cell lymphoma: our expirience Abstr.33 Bilt. Hematol 2007; 35(3): (serbian) 59. Popovic L., Jovanovic D., Petrovic D., Matovina G., Roganovic T. Breast involving lymphoma: report of four cases Abstr. 35 Bilt. Hematol 2007; 35(3): (serbian) 60. Popovic L., Jovanovic D., Petrovic D., Matovina G., Roganovic T. ALK-negative anaplastic large T-cell lymphoma in a muscle: case report and review of literature Abstr. 44 Bilt. Hematol 2007; 35(3): (serbian) 61. Matovina G., Jovanovic D., Fabri M., Petrovic D., Popovic L., Roganovic T. Heapatitis B viral infection reactivation during induction lymphoma therapy: report of two cases Abstrakt br. 54 Bilt. Hematol 2007; 35(3): (serbian) 62. Tešanovic S. Popovic L:. «Efficacy of lower dose capacitabine in metastatic breast cancer» Sr. Kamenica (serbian) 63. Popovic L. «Quality of life in different insuline therapy regimen (CIT, MSII)» Limsc Leiden Holland 2005.